1,841 followers
Cost-effectiveness of the 21-gene recurrence score assay in decision making to guide early-stage breast cancer chemo http://t.co/fO6oWGbBbl
Cost-effectiveness of the 21-gene recurrence score assay in decision making to guide early-stage breast cancer chemo http://t.co/fO6oWGbBbl
New study: cost-effectiveness of #gene score assay in guiding chemotherapy for early-stage breast cancer http://t.co/moU51r2E
More on genomic tests MT @DrKhouryCDC: cost-effectiveness of 21-gene score assay in guiding chemo 4 early breast cancer http://t.co/jwRrfGUU
More on genomic tests MT @DrKhouryCDC: cost-effectiveness of 21-gene score assay in guiding chemo 4 early breast cancer http://t.co/jwRrfGUU